Curdlan sulfate
Alternative Names: CRDSLatest Information Update: 23 Mar 2007
At a glance
- Originator Ajinomoto
- Class Beta Glucans
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; Malaria
Most Recent Events
- 23 Mar 2007 No development reported - Phase-II for HIV infections treatment in Japan (IV)
- 23 Mar 2007 No development reported - Phase-II for HIV infections treatment in USA (IV)
- 23 Mar 2007 No development reported - Phase-II for Malaria in Africa (IV)